2014
Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs
Publication
Publication
E M B O Reports , Volume 15 - Issue 5 p. 472- 476
Recent advances in genomics and sequencing technology herald the advent of pharmacogenomics in routine clinical practice. Yet, while science and technology have progressed rapidly, legal, social and ethical challenges remain to be resolved.
Additional Metadata | |
---|---|
doi.org/10.1002/embr.201438641, hdl.handle.net/1765/59401 | |
E M B O Reports | |
Organisation | Department of Clinical Chemistry |
Kampourakis, K., Vayena, E., Mitropoulou, C., van Schaik, R., Cooper, D., Borg, J., & Patrinos, G. (2014). Key challenges for next-generation pharmacogenomics: Science & Society series on Science and Drugs. E M B O Reports, 15(5), 472–476. doi:10.1002/embr.201438641 |